26 Oct 2020- SDIP Innovations has been awarded over $2.7M from the NSW Health Fund for the JAZBI™ bioresorbable platform technology. A total of $5 M was awarded to two companies for the 2020 round of the Medical Devices Fund. Since the first round in 2013, recipients of the NSW Medical Devices Fund have been awarded more than $60 million for 36 technologies.
Further information on the fund and recipients can be fund HERE.
SDIP Innovations was selected to be one of the 2020 Rosenman Innovators. The UCSF Rosenman Institute provides startups with expertise and mentorship from stakeholders across the healthcare industry.
SDIP Innovations has been selected as a finalist for the prestigious national Start-Up Stadium competition organized by BIO, the world's largest biotech trade association.
We are proud to announce that Fred Dinger has joined to SDIP Innovations. Fred has more than 25 years’ experience with both large and start-up medical device companies. He was the CEO of OsteoBiologics Inc., a bioresorbable implant start-up sold to Smith & Nephews. He is the CEO of Arin Medical. Fred was CEO of 3 start-ups creating hundreds of million dollars in acquisition value.
Our CEO Dr Maryam Parviz was one of the panellist at Cannon Quality Group Panel Discussion on manufacturing in Redwood City. Attendees got the benefit of a lot of experience from both the supplier side and the developer side on keys to successful collaboration.
SDIP was among the MTP Connect delegates participating in MedTech conference in Boston from September 23–25, 2019. More than 3,300 of the world’s top MedTech executives gathered in Boston, MA, for the leading event in health industry — The MedTech Conference.